How it Works
Try Naxlex NCLEX-RN (14-day Free-Trial)

Treatment and Management of Hemophilia

- The treatment and management of hemophilia involves a multidisciplinary approach that includes hematologists, nurses, physical therapists, dentists, psychologists, social workers, and genetic counselors.

- The main goals are to prevent bleeding episodes, treat bleeding episodes promptly, prevent joint damage and organ dysfunction, manage pain and complications, improve quality of life, and reduce mortality.

- The main modalities are factor replacement therapy, antifibrinolytic agents, desmopressin acetate (DDAVP), gene therapy, and supportive care.

- Factor replacement therapy is the administration of recombinant or plasma-derived factor VIII or factor IX concentrates to restore normal clotting function. It can be given on demand or prophylactically. The dose and frequency depend on the type and severity of hemophilia, the level of factor activity desired, the site and extent of bleeding, and the presence of inhibitors.

- Antifibrinolytic agents are drugs that inhibit the breakdown of fibrin clots by blocking plasminogen activation. They are used as adjunctive therapy for mucosal bleeding such as epistaxis, oral bleeding, gastrointestinal bleeding, and menorrhagia. Examples are tranexamic acid and aminocaproic acid.

- Desmopressin acetate (DDAVP) is a synthetic analog of vasopressin that stimulates the release of factor VIII and von Willebrand factor from endothelial cells. It is used for mild to moderate hemophilia A or von Willebrand disease. It can be given intravenously, subcutaneously, intranasally, or orally.

- Gene therapy is an experimental approach that aims to correct the defective gene that causes hemophilia by introducing a normal copy of the gene into the patient’s cells. It has shown promising results in clinical trials

Questions on Treatment and Management of Hemophilia

Correct Answer is D

Explanation

This statement is incorrect. While it is very rare for females to have hemophilia, it is not impossible. Females can inherit hemophilia if they have two affected X chromosomes or if they inherit one affected X chromosome and one affected Y chromosome. Therefore, this statement does not indicate a need for further teaching.

Correct Answer is A

Explanation

Hemophilia A is not caused by a deficiency of vitamin K. Vitamin K deficiency can lead to bleeding disorders, but it is not the cause of hemophilia A. This statement is incorrect.

Correct Answer is ["A","C","E"]

Explanation

Spontaneous nosebleeds are a common clinical manifestation of hemophilia. The fragile blood vessels in the nose can rupture easily, leading to spontaneous nosebleeds. This choice is correct.

Correct Answer is C

Explanation

Hyperlipidemia refers to high levels of lipids (fats) in the blood, such as cholesterol and triglycerides. It is not a common complication of hemophilia, and there is no direct link between hemophilia and hyperlipidemia. Therefore, it is not a priority in the care plan for a client with hemophilia.

Correct Answer is C

Explanation

Administering iron supplements to improve hemoglobin levels is not a direct treatment for hemophilia. Hemophilia is a clotting disorder, and iron supplements are typically used to treat conditions related to iron deficiency anemia. While individuals with hemophilia may experience anemia as a result of chronic bleeding, the primary treatment for hemophilia involves addressing the clotting factor deficiency through factor replacement therapy. .

Correct Answer is C

Explanation

"You should perform strenuous exercises to improve joint mobility." Encouraging strenuous exercises in a client with hemophilia who is already experiencing joint pain and swelling is not advisable. Strenuous exercise can exacerbate bleeding and joint damage. Instead, the focus should be on gentle range-of-motion exercises and physical therapy, guided by a healthcare provider, to improve joint mobility without increasing the risk of bleeding.

Correct Answer is C

Explanation

"This bleeding is normal and should resolve on its own." Rationale: This statement is incorrect and potentially dangerous. Bleeding in a client with hemophilia is not normal and should not be left untreated. Without intervention, it can lead to severe complications and even life-threatening situations.

Correct Answer is ["A","C","E"]

Explanation

Fibrinogen levels. Rationale: Fibrinogen levels are not typically used to diagnose hemophilia. Hemophilia is characterized by deficiencies in specific clotting factors (Factor VIII or Factor IX), and fibrinogen levels are not directly related to these factors.

Allergies to latex products. Rationale: While allergies to latex products should be assessed for safety reasons, it is not directly related to the diagnosis of hemophilia. This information is important for overall patient safety but is not a specific factor in diagnosing hemophilia.

"Have you been prescribed antifibrinolytic agents?” This question pertains to treatment rather than the assessment of the type and severity of hemophilia. It is important to know the treatment history but does not provide direct insight into the condition's severity.

"Encourage the client to perform vigorous physical exercises." Encouraging vigorous physical exercises is not advisable for clients with hemophilia, especially when they are experiencing joint pain. It can increase the risk of bleeding and further joint damage.

Applying heat to bleeding joints to alleviate pain is not a recommended practice for patients with hemophilia. Heat can increase blood flow to the affected area, potentially exacerbating bleeding. Cold therapy, such as ice packs, is often recommended to reduce inflammation and pain while minimizing

Gene therapy is an emerging treatment approach for hemophilia, but it does not stimulate the release of factor VIII and von Willebrand factor from endothelial cells. Gene therapy aims to provide a long-term solution by introducing functional clotting factor genes into the patient's body.

Gene therapy is an emerging treatment for hemophilia, but it does not directly address the breakdown of fibrin clots. It aims to provide a long-term solution by introducing functional clotting factor genes into the patient's body, but it may not be the immediate choice for managing acute bleeding ep

<p>The client is at risk for thrombosis.<br /> This choice is incorrect.<br /> Hemophilia is associated with bleeding tendencies, not an increased risk of thrombosis.<br /> Prolonged PTT indicates a reduced ability to form clots, making thrombosis less likely.</p>
Try Naxlex NCLEX-RN
(14 Day Free-Trial)

Search Here

Related Topics

More on Nursing

Free Nursing Study Materials

Access to all study guides and practice questions for nursing for free.

  • Free Nursing Study Trials
  • Free Nursing Video tutorials
  • Free Nursing Practice Tests
  • Free Exam and Study Modes
  • Free Nursing Revision Quizlets
Join Us Today